Genetic markers of risk for ST-elevated myocardial infarction
نویسندگان
چکیده
منابع مشابه
Genetic Markers of Myocardial Infarction
Myocardial Infarction (MI) is a complex multifactorial disorder caused by the interaction of environmental and genetic factors. Several types of genetic studies and approaches, such as family studies, linkage analysis, candidate gene approach, and genome wide association studies, have tried to unravel the genetic background of MI. Although it is clear that the genetic component has an important...
متن کاملLeft Ventricular Thrombus in Acute St Segment Elevated Myocardial Infarction
Objectives: To determine the frequency of left ventricular thrombus in acute ST segment elevation myocardial infarction, relation of left ventricular thrombus to degree of left ventricular-dysfunction, and effects of adjuvant therapy on left ventricular thrombus formation. Material & Methods: It was a descriptive cross sectional study conducted at Cardiology Department, Hayatabad Medical Comple...
متن کاملPlatelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction
BACKGROUND Platelet-to-lymphocyte ratio (PLR) is a new prognostic marker in coronary artery disease. We aimed to evaluate the relationship between PLR and in-hospital mortality in patients with ST-elevated acute myocardial infarction (AMI). MATERIAL AND METHODS The present study included 636 patients with ST-elevated AMI. The study population was divided into tertiles based on their admission...
متن کاملThe effect of tirofiban on ST segment resolution in patients with non-ST elevated myocardial infarction.
ST segment resolution in ST elevated myocardial infarction has independent predictive value for congestive heart failure and death at 30 days. ST segment depression in unstable angina pectoris (UAP) and non-ST elevated myocardial infarction (NSTEMI) predicts high risk of MI and death and may discriminate patients likely to have greater benefit from aggressive antithrombotic and interventional t...
متن کاملComparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial
Objective: Heparin and enoxaparin possess anti-inflammatory properties. We compared the effects of these drugs on inflammatory biomarkers in patients with ST-segment Elevated Myocardial Infarction (STEMI). Method: Thirty four patients with STEMI randomly separated in two groups and received standard doses of heparin and enoxaparin. The serum concentration of Serum Amyloid A (SAA), C-Reactive Pr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Russian Journal of Cardiology
سال: 2019
ISSN: 2618-7620,1560-4071
DOI: 10.15829/1560-4071-2019-10-53-57